Time-dependent exposure to inhaled ipratropium bromide was characterized as exposed vs unexposed within the past year, and recency of exposure and cumulative exposure within the past year.

Several single-dose studies comparing acute bronchodilation induced by ipratropium bromide with salbutamol have shown that salbutamol was more effective than ipratropium in asthma treatment.

Ipratropium bromide 0.5 mg/3 mL (0.017%), albuterol (as sulfate) 2.5 mg/3 mL (0.083%); soln for inh. Not for primary treatment of acute attack. Avoid excessive use. Discontinue if paradoxical ...

Ipratropium bromide 0.06% (42mcg/spray); aqueous soln. Ipratropium bromide, an anticholinergic (parasympatholytic) agent, has antisecretory properties which inhibit secretions from the serous and ...

Atrovent Inhalation Solution contains the active ingredient ipratropium bromide monohydrate. It belongs to a group of medicines called anticholinergic bronchodilators. Atrovent Inhalation Solution ...

Not currently distributed in Australia. Each 1 mL of Atrovent Adult UDV contains 522 micrograms of ipratropium bromide monohydrate (equivalent to 500 micrograms of ipratropium bromide) as the ...

The inhalers affected by this price cap include: - Combivent Respimat (ipratropium bromide and albuterol) inhalation spray - ...

The drugs for which the retail prices fix include two formulations of bisoprolol and amlodipine tablet marketed by Abbott Healthcare, gentamicin and dexamethasone eye drops and another formulation of ...